Q# 16-09: Fluconazole and Risk Fetal Events during Pregnancy

This project aims to investigate the association between use of fluconazole, a systemic azole antifungal drug treating vulvovaginal candidiasis, during pregnancy and the risk of spontaneous abortion, still birth or major birth defects/congenital malformations and under what conditions these situations occur (timing [first, second or third trimester, or throughout pregnancy], dosing [single 150 mg or less fluconazole dose, cumulative dosing]). A full report for this query was prepared. A manuscript is in revision with plans to submit to CMAJ by the end of July.

For more information contact: Autumn Neville. Research Coordinator. autumn.neville@rimuhc.ca   514.934.1934 ext.44844 or ext.44718

Comments are closed.